nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—nerve—alcohol dependence	0.0442	0.286	CbGeAlD
Fosaprepitant—TACR1—Peptide GPCRs—OPRK1—alcohol dependence	0.0196	0.0789	CbGpPWpGaD
Fosaprepitant—TACR1—brainstem—alcohol dependence	0.019	0.123	CbGeAlD
Fosaprepitant—TACR1—forebrain—alcohol dependence	0.0183	0.119	CbGeAlD
Fosaprepitant—TACR1—Peptide GPCRs—OPRD1—alcohol dependence	0.0132	0.053	CbGpPWpGaD
Fosaprepitant—TACR1—digestive system—alcohol dependence	0.0128	0.0832	CbGeAlD
Fosaprepitant—TACR1—blood—alcohol dependence	0.0122	0.0793	CbGeAlD
Fosaprepitant—TACR1—endocrine gland—alcohol dependence	0.0106	0.0688	CbGeAlD
Fosaprepitant—TACR1—testis—alcohol dependence	0.0101	0.0656	CbGeAlD
Fosaprepitant—TACR1—Peptide GPCRs—OPRM1—alcohol dependence	0.0101	0.0408	CbGpPWpGaD
Fosaprepitant—TACR1—nervous system—alcohol dependence	0.00994	0.0644	CbGeAlD
Fosaprepitant—TACR1—central nervous system—alcohol dependence	0.00957	0.062	CbGeAlD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00921	0.0371	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—PDYN—alcohol dependence	0.00869	0.035	CbGpPWpGaD
Fosaprepitant—TACR1—brain—alcohol dependence	0.0076	0.0492	CbGeAlD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.00619	0.0249	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00618	0.0249	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00607	0.0245	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00593	0.0239	CbGpPWpGaD
Fosaprepitant—Hypoaesthesia—Disulfiram—alcohol dependence	0.00477	0.00798	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00476	0.0192	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—OPRK1—alcohol dependence	0.0047	0.019	CbGpPWpGaD
Fosaprepitant—Eructation—Acamprosate—alcohol dependence	0.00462	0.00773	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.0046	0.0185	CbGpPWpGaD
Fosaprepitant—Haematoma—Citalopram—alcohol dependence	0.00448	0.00751	CcSEcCtD
Fosaprepitant—Blood pressure increased—Naltrexone—alcohol dependence	0.00445	0.00745	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00438	0.0177	CbGpPWpGaD
Fosaprepitant—Upset stomach—Citalopram—alcohol dependence	0.0043	0.0072	CcSEcCtD
Fosaprepitant—Urine output increased—Acamprosate—alcohol dependence	0.00425	0.00711	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00415	0.0167	CbGpPWpGaD
Fosaprepitant—Haemoglobin decreased—Citalopram—alcohol dependence	0.0041	0.00685	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00398	0.016	CbGpPWpGaD
Fosaprepitant—Thrombophlebitis—Acamprosate—alcohol dependence	0.00394	0.0066	CcSEcCtD
Fosaprepitant—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.00392	0.00657	CcSEcCtD
Fosaprepitant—Euphoric mood—Naltrexone—alcohol dependence	0.00382	0.0064	CcSEcCtD
Fosaprepitant—Disorientation—Naltrexone—alcohol dependence	0.00361	0.00604	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00348	0.014	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.00346	0.014	CbGpPWpGaD
Fosaprepitant—Hot flush—Naltrexone—alcohol dependence	0.00345	0.00578	CcSEcCtD
Fosaprepitant—Hyponatraemia—Acamprosate—alcohol dependence	0.00343	0.00574	CcSEcCtD
Fosaprepitant—Menopausal symptoms—Naltrexone—alcohol dependence	0.00342	0.00573	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.00339	0.0137	CbGpPWpGaD
Fosaprepitant—Lethargy—Naltrexone—alcohol dependence	0.0033	0.00552	CcSEcCtD
Fosaprepitant—Cardiovascular disorder—Citalopram—alcohol dependence	0.00321	0.00537	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00319	0.0129	CbGpPWpGaD
Fosaprepitant—Chest discomfort—Citalopram—alcohol dependence	0.00319	0.00533	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—OPRD1—alcohol dependence	0.00316	0.0127	CbGpPWpGaD
Fosaprepitant—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00312	0.00522	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00307	0.00514	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—PDYN—alcohol dependence	0.00303	0.0122	CbGpPWpGaD
Fosaprepitant—Somnolence—Disulfiram—alcohol dependence	0.00303	0.00507	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00301	0.00504	CcSEcCtD
Fosaprepitant—Dysarthria—Citalopram—alcohol dependence	0.00298	0.00499	CcSEcCtD
Fosaprepitant—Blood bilirubin increased—Citalopram—alcohol dependence	0.00298	0.00499	CcSEcCtD
Fosaprepitant—Abdominal distension—Acamprosate—alcohol dependence	0.00297	0.00497	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Naltrexone—alcohol dependence	0.00295	0.00494	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00294	0.0118	CbGpPWpGaD
Fosaprepitant—Fatigue—Disulfiram—alcohol dependence	0.00294	0.00491	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—AVP—alcohol dependence	0.00293	0.0118	CbGpPWpGaD
Fosaprepitant—Pain—Disulfiram—alcohol dependence	0.00291	0.00487	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00291	0.00487	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—AVP—alcohol dependence	0.0029	0.0117	CbGpPWpGaD
Fosaprepitant—Gait disturbance—Citalopram—alcohol dependence	0.00289	0.00483	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00285	0.00477	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00284	0.0114	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.00282	0.0114	CbGpPWpGaD
Fosaprepitant—Hiccups—Citalopram—alcohol dependence	0.00282	0.00472	CcSEcCtD
Fosaprepitant—Blood pressure increased—Citalopram—alcohol dependence	0.00282	0.00472	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CRHR1—alcohol dependence	0.00282	0.0114	CbGpPWpGaD
Fosaprepitant—Eructation—Citalopram—alcohol dependence	0.00277	0.00463	CcSEcCtD
Fosaprepitant—Wheezing—Citalopram—alcohol dependence	0.00274	0.00458	CcSEcCtD
Fosaprepitant—Pollakiuria—Acamprosate—alcohol dependence	0.00272	0.00456	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00269	0.00451	CcSEcCtD
Fosaprepitant—Candida infection—Citalopram—alcohol dependence	0.00269	0.0045	CcSEcCtD
Fosaprepitant—Abdominal discomfort—Naltrexone—alcohol dependence	0.00268	0.00448	CcSEcCtD
Fosaprepitant—Weight decreased—Acamprosate—alcohol dependence	0.00267	0.00447	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—OPRK1—alcohol dependence	0.00266	0.0107	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CHRM2—alcohol dependence	0.00265	0.0107	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.00262	0.0106	CbGpPWpGaD
Fosaprepitant—Stomatitis—Acamprosate—alcohol dependence	0.00256	0.00429	CcSEcCtD
Fosaprepitant—Urinary tract infection—Acamprosate—alcohol dependence	0.00256	0.00428	CcSEcCtD
Fosaprepitant—Urine output increased—Citalopram—alcohol dependence	0.00255	0.00427	CcSEcCtD
Fosaprepitant—Weight decreased—Naltrexone—alcohol dependence	0.00252	0.00423	CcSEcCtD
Fosaprepitant—Haematuria—Acamprosate—alcohol dependence	0.00251	0.0042	CcSEcCtD
Fosaprepitant—Infestation—Naltrexone—alcohol dependence	0.00249	0.00416	CcSEcCtD
Fosaprepitant—Infestation NOS—Naltrexone—alcohol dependence	0.00249	0.00416	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00248	0.00999	CbGpPWpGaD
Fosaprepitant—Asthenia—Disulfiram—alcohol dependence	0.00244	0.00409	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2A—alcohol dependence	0.00244	0.00984	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—OPRM1—alcohol dependence	0.00243	0.0098	CbGpPWpGaD
Fosaprepitant—Euphoric mood—Citalopram—alcohol dependence	0.00242	0.00405	CcSEcCtD
Fosaprepitant—Urinary tract infection—Naltrexone—alcohol dependence	0.00242	0.00405	CcSEcCtD
Fosaprepitant—Conjunctivitis—Naltrexone—alcohol dependence	0.00242	0.00405	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—OPRK1—alcohol dependence	0.00241	0.00973	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.00237	0.00954	CbGpPWpGaD
Fosaprepitant—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00235	0.00394	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Acamprosate—alcohol dependence	0.00235	0.00393	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00231	0.00931	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00231	0.00931	CbGpPWpGaD
Fosaprepitant—Disorientation—Citalopram—alcohol dependence	0.00229	0.00383	CcSEcCtD
Fosaprepitant—Dizziness—Disulfiram—alcohol dependence	0.00225	0.00377	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—NPY—alcohol dependence	0.00224	0.00902	CbGpPWpGaD
Fosaprepitant—Tinnitus—Acamprosate—alcohol dependence	0.0022	0.00368	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Naltrexone—alcohol dependence	0.0022	0.00367	CcSEcCtD
Fosaprepitant—Hot flush—Citalopram—alcohol dependence	0.00219	0.00366	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.00218	0.0088	CbGpPWpGaD
Fosaprepitant—Menopausal symptoms—Citalopram—alcohol dependence	0.00217	0.00363	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CRH—alcohol dependence	0.00216	0.0087	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR1B—alcohol dependence	0.00216	0.0087	CbGpPWpGaD
Fosaprepitant—Rash—Disulfiram—alcohol dependence	0.00215	0.00359	CcSEcCtD
Fosaprepitant—Headache—Disulfiram—alcohol dependence	0.00213	0.00357	CcSEcCtD
Fosaprepitant—Immune system disorder—Acamprosate—alcohol dependence	0.00213	0.00357	CcSEcCtD
Fosaprepitant—Lethargy—Citalopram—alcohol dependence	0.00209	0.00349	CcSEcCtD
Fosaprepitant—Eye disorder—Naltrexone—alcohol dependence	0.00209	0.00349	CcSEcCtD
Fosaprepitant—Tinnitus—Naltrexone—alcohol dependence	0.00208	0.00349	CcSEcCtD
Fosaprepitant—Cardiac disorder—Naltrexone—alcohol dependence	0.00207	0.00347	CcSEcCtD
Fosaprepitant—Mental disorder—Acamprosate—alcohol dependence	0.00207	0.00346	CcSEcCtD
Fosaprepitant—Malnutrition—Acamprosate—alcohol dependence	0.00206	0.00344	CcSEcCtD
Fosaprepitant—Hyponatraemia—Citalopram—alcohol dependence	0.00205	0.00344	CcSEcCtD
Fosaprepitant—Osteoarthritis—Citalopram—alcohol dependence	0.00205	0.00342	CcSEcCtD
Fosaprepitant—Angiopathy—Naltrexone—alcohol dependence	0.00203	0.00339	CcSEcCtD
Fosaprepitant—Flatulence—Acamprosate—alcohol dependence	0.00203	0.00339	CcSEcCtD
Fosaprepitant—Immune system disorder—Naltrexone—alcohol dependence	0.00202	0.00338	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Naltrexone—alcohol dependence	0.00201	0.00337	CcSEcCtD
Fosaprepitant—Dysgeusia—Acamprosate—alcohol dependence	0.00201	0.00337	CcSEcCtD
Fosaprepitant—Muscle spasms—Acamprosate—alcohol dependence	0.00198	0.00331	CcSEcCtD
Fosaprepitant—Mental disorder—Naltrexone—alcohol dependence	0.00196	0.00328	CcSEcCtD
Fosaprepitant—Malnutrition—Naltrexone—alcohol dependence	0.00194	0.00325	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.00194	0.00783	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—alcohol dependence	0.00193	0.00776	CbGpPWpGaD
Fosaprepitant—Flatulence—Naltrexone—alcohol dependence	0.00192	0.00321	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Acamprosate—alcohol dependence	0.00191	0.00319	CcSEcCtD
Fosaprepitant—Dysgeusia—Naltrexone—alcohol dependence	0.0019	0.00319	CcSEcCtD
Fosaprepitant—Anaemia—Acamprosate—alcohol dependence	0.0019	0.00318	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—DRD4—alcohol dependence	0.00189	0.00761	CbGpPWpGaD
Fosaprepitant—Angioedema—Acamprosate—alcohol dependence	0.00188	0.00314	CcSEcCtD
Fosaprepitant—Muscle spasms—Naltrexone—alcohol dependence	0.00187	0.00313	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Citalopram—alcohol dependence	0.00187	0.00313	CcSEcCtD
Fosaprepitant—Hypokalaemia—Citalopram—alcohol dependence	0.00186	0.00312	CcSEcCtD
Fosaprepitant—Malaise—Acamprosate—alcohol dependence	0.00185	0.0031	CcSEcCtD
Fosaprepitant—Syncope—Acamprosate—alcohol dependence	0.00184	0.00308	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00184	0.00308	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00184	0.00308	CcSEcCtD
Fosaprepitant—Palpitations—Acamprosate—alcohol dependence	0.00182	0.00304	CcSEcCtD
Fosaprepitant—Loss of consciousness—Acamprosate—alcohol dependence	0.00181	0.00302	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.0018	0.00302	CcSEcCtD
Fosaprepitant—Muscular weakness—Citalopram—alcohol dependence	0.0018	0.00302	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Naltrexone—alcohol dependence	0.0018	0.00302	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CNR1—alcohol dependence	0.0018	0.00726	CbGpPWpGaD
Fosaprepitant—Cough—Acamprosate—alcohol dependence	0.00179	0.003	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—OPRD1—alcohol dependence	0.00179	0.0072	CbGpPWpGaD
Fosaprepitant—Abdominal distension—Citalopram—alcohol dependence	0.00178	0.00298	CcSEcCtD
Fosaprepitant—Angioedema—Naltrexone—alcohol dependence	0.00178	0.00297	CcSEcCtD
Fosaprepitant—Hypertension—Acamprosate—alcohol dependence	0.00177	0.00297	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—DRD2—alcohol dependence	0.00176	0.00709	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR7—alcohol dependence	0.00176	0.00709	CbGpPWpGaD
Fosaprepitant—Malaise—Naltrexone—alcohol dependence	0.00175	0.00294	CcSEcCtD
Fosaprepitant—Chest pain—Acamprosate—alcohol dependence	0.00175	0.00293	CcSEcCtD
Fosaprepitant—Syncope—Naltrexone—alcohol dependence	0.00174	0.00292	CcSEcCtD
Fosaprepitant—Anxiety—Acamprosate—alcohol dependence	0.00174	0.00292	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00174	0.00291	CcSEcCtD
Fosaprepitant—Discomfort—Acamprosate—alcohol dependence	0.00173	0.00289	CcSEcCtD
Fosaprepitant—Palpitations—Naltrexone—alcohol dependence	0.00172	0.00288	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PDYN—alcohol dependence	0.00171	0.0069	CbGpPWpGaD
Fosaprepitant—Dry mouth—Acamprosate—alcohol dependence	0.00171	0.00286	CcSEcCtD
Fosaprepitant—Loss of consciousness—Naltrexone—alcohol dependence	0.00171	0.00286	CcSEcCtD
Fosaprepitant—Cough—Naltrexone—alcohol dependence	0.0017	0.00284	CcSEcCtD
Fosaprepitant—Abdominal discomfort—Citalopram—alcohol dependence	0.0017	0.00284	CcSEcCtD
Fosaprepitant—Hypertension—Naltrexone—alcohol dependence	0.00168	0.00281	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Acamprosate—alcohol dependence	0.00168	0.00281	CcSEcCtD
Fosaprepitant—Infection—Acamprosate—alcohol dependence	0.00167	0.00279	CcSEcCtD
Fosaprepitant—Chest pain—Naltrexone—alcohol dependence	0.00166	0.00277	CcSEcCtD
Fosaprepitant—Dysuria—Citalopram—alcohol dependence	0.00165	0.00277	CcSEcCtD
Fosaprepitant—Shock—Acamprosate—alcohol dependence	0.00165	0.00276	CcSEcCtD
Fosaprepitant—Anxiety—Naltrexone—alcohol dependence	0.00165	0.00276	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00164	0.00275	CcSEcCtD
Fosaprepitant—Discomfort—Naltrexone—alcohol dependence	0.00164	0.00274	CcSEcCtD
Fosaprepitant—Pollakiuria—Citalopram—alcohol dependence	0.00163	0.00273	CcSEcCtD
Fosaprepitant—Skin disorder—Acamprosate—alcohol dependence	0.00163	0.00273	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—OPRD1—alcohol dependence	0.00162	0.00654	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Acamprosate—alcohol dependence	0.00162	0.00271	CcSEcCtD
Fosaprepitant—Dry mouth—Naltrexone—alcohol dependence	0.00162	0.00271	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00162	0.00652	CbGpPWpGaD
Fosaprepitant—Photosensitivity reaction—Citalopram—alcohol dependence	0.00161	0.0027	CcSEcCtD
Fosaprepitant—Weight decreased—Citalopram—alcohol dependence	0.0016	0.00268	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CRHR1—alcohol dependence	0.00159	0.00642	CbGpPWpGaD
Fosaprepitant—Anaphylactic shock—Naltrexone—alcohol dependence	0.00159	0.00266	CcSEcCtD
Fosaprepitant—Oedema—Naltrexone—alcohol dependence	0.00159	0.00266	CcSEcCtD
Fosaprepitant—Infection—Naltrexone—alcohol dependence	0.00158	0.00264	CcSEcCtD
Fosaprepitant—Infestation NOS—Citalopram—alcohol dependence	0.00158	0.00264	CcSEcCtD
Fosaprepitant—Infestation—Citalopram—alcohol dependence	0.00158	0.00264	CcSEcCtD
Fosaprepitant—Hypotension—Acamprosate—alcohol dependence	0.00157	0.00262	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00156	0.00262	CcSEcCtD
Fosaprepitant—Shock—Naltrexone—alcohol dependence	0.00156	0.00261	CcSEcCtD
Fosaprepitant—Nervous system disorder—Naltrexone—alcohol dependence	0.00156	0.0026	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—PDYN—alcohol dependence	0.00156	0.00627	CbGpPWpGaD
Fosaprepitant—Skin disorder—Naltrexone—alcohol dependence	0.00154	0.00258	CcSEcCtD
Fosaprepitant—Stomatitis—Citalopram—alcohol dependence	0.00154	0.00257	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Naltrexone—alcohol dependence	0.00153	0.00257	CcSEcCtD
Fosaprepitant—Conjunctivitis—Citalopram—alcohol dependence	0.00153	0.00257	CcSEcCtD
Fosaprepitant—Urinary tract infection—Citalopram—alcohol dependence	0.00153	0.00257	CcSEcCtD
Fosaprepitant—Insomnia—Acamprosate—alcohol dependence	0.00152	0.00254	CcSEcCtD
Fosaprepitant—Haematuria—Citalopram—alcohol dependence	0.0015	0.00252	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CHRM2—alcohol dependence	0.0015	0.00603	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.0015	0.00603	CbGpPWpGaD
Fosaprepitant—Dyspnoea—Acamprosate—alcohol dependence	0.0015	0.0025	CcSEcCtD
Fosaprepitant—Somnolence—Acamprosate—alcohol dependence	0.00149	0.0025	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—AVP—alcohol dependence	0.00148	0.00596	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Acamprosate—alcohol dependence	0.00148	0.00247	CcSEcCtD
Fosaprepitant—Decreased appetite—Acamprosate—alcohol dependence	0.00146	0.00244	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00145	0.00242	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CRHR1—alcohol dependence	0.00145	0.00583	CbGpPWpGaD
Fosaprepitant—Bradycardia—Citalopram—alcohol dependence	0.00144	0.00241	CcSEcCtD
Fosaprepitant—Insomnia—Naltrexone—alcohol dependence	0.00144	0.0024	CcSEcCtD
Fosaprepitant—Pain—Acamprosate—alcohol dependence	0.00143	0.0024	CcSEcCtD
Fosaprepitant—Constipation—Acamprosate—alcohol dependence	0.00143	0.0024	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—OPRK1—alcohol dependence	0.00143	0.00575	CbGpPWpGaD
Fosaprepitant—Dyspnoea—Naltrexone—alcohol dependence	0.00141	0.00237	CcSEcCtD
Fosaprepitant—Somnolence—Naltrexone—alcohol dependence	0.00141	0.00236	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Citalopram—alcohol dependence	0.00141	0.00236	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Citalopram—alcohol dependence	0.0014	0.00234	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Citalopram—alcohol dependence	0.00139	0.00233	CcSEcCtD
Fosaprepitant—Urethral disorder—Citalopram—alcohol dependence	0.00139	0.00232	CcSEcCtD
Fosaprepitant—Feeling abnormal—Acamprosate—alcohol dependence	0.00138	0.00231	CcSEcCtD
Fosaprepitant—Decreased appetite—Naltrexone—alcohol dependence	0.00138	0.00231	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—OPRM1—alcohol dependence	0.00137	0.00554	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00137	0.0023	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00137	0.00229	CcSEcCtD
Fosaprepitant—Fatigue—Naltrexone—alcohol dependence	0.00137	0.00229	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CHRM2—alcohol dependence	0.00136	0.00548	CbGpPWpGaD
Fosaprepitant—Constipation—Naltrexone—alcohol dependence	0.00136	0.00227	CcSEcCtD
Fosaprepitant—Pain—Naltrexone—alcohol dependence	0.00136	0.00227	CcSEcCtD
Fosaprepitant—Erythema multiforme—Citalopram—alcohol dependence	0.00134	0.00224	CcSEcCtD
Fosaprepitant—Urticaria—Acamprosate—alcohol dependence	0.00133	0.00223	CcSEcCtD
Fosaprepitant—Abdominal pain—Acamprosate—alcohol dependence	0.00133	0.00222	CcSEcCtD
Fosaprepitant—Body temperature increased—Acamprosate—alcohol dependence	0.00133	0.00222	CcSEcCtD
Fosaprepitant—Eye disorder—Citalopram—alcohol dependence	0.00132	0.00221	CcSEcCtD
Fosaprepitant—Tinnitus—Citalopram—alcohol dependence	0.00132	0.00221	CcSEcCtD
Fosaprepitant—Flushing—Citalopram—alcohol dependence	0.00131	0.0022	CcSEcCtD
Fosaprepitant—Cardiac disorder—Citalopram—alcohol dependence	0.00131	0.0022	CcSEcCtD
Fosaprepitant—Feeling abnormal—Naltrexone—alcohol dependence	0.00131	0.00219	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Naltrexone—alcohol dependence	0.0013	0.00217	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.00129	0.00521	CbGpPWpGaD
Fosaprepitant—Angiopathy—Citalopram—alcohol dependence	0.00128	0.00215	CcSEcCtD
Fosaprepitant—Immune system disorder—Citalopram—alcohol dependence	0.00128	0.00214	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Citalopram—alcohol dependence	0.00128	0.00213	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—NPY—alcohol dependence	0.00127	0.0051	CbGpPWpGaD
Fosaprepitant—Urticaria—Naltrexone—alcohol dependence	0.00126	0.00211	CcSEcCtD
Fosaprepitant—Abdominal pain—Naltrexone—alcohol dependence	0.00125	0.0021	CcSEcCtD
Fosaprepitant—Body temperature increased—Naltrexone—alcohol dependence	0.00125	0.0021	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—OPRM1—alcohol dependence	0.00125	0.00503	CbGpPWpGaD
Fosaprepitant—Mental disorder—Citalopram—alcohol dependence	0.00124	0.00208	CcSEcCtD
Fosaprepitant—Hypersensitivity—Acamprosate—alcohol dependence	0.00124	0.00207	CcSEcCtD
Fosaprepitant—Erythema—Citalopram—alcohol dependence	0.00123	0.00206	CcSEcCtD
Fosaprepitant—Malnutrition—Citalopram—alcohol dependence	0.00123	0.00206	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2A—alcohol dependence	0.00123	0.00496	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR1B—alcohol dependence	0.00122	0.00492	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CRH—alcohol dependence	0.00122	0.00492	CbGpPWpGaD
Fosaprepitant—Flatulence—Citalopram—alcohol dependence	0.00121	0.00203	CcSEcCtD
Fosaprepitant—Dysgeusia—Citalopram—alcohol dependence	0.00121	0.00202	CcSEcCtD
Fosaprepitant—Asthenia—Acamprosate—alcohol dependence	0.0012	0.00201	CcSEcCtD
Fosaprepitant—Pruritus—Acamprosate—alcohol dependence	0.00119	0.00199	CcSEcCtD
Fosaprepitant—Muscle spasms—Citalopram—alcohol dependence	0.00118	0.00198	CcSEcCtD
Fosaprepitant—Hypersensitivity—Naltrexone—alcohol dependence	0.00117	0.00196	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—NPY—alcohol dependence	0.00115	0.00463	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Acamprosate—alcohol dependence	0.00115	0.00192	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Citalopram—alcohol dependence	0.00114	0.00191	CcSEcCtD
Fosaprepitant—Anaemia—Citalopram—alcohol dependence	0.00114	0.00191	CcSEcCtD
Fosaprepitant—Asthenia—Naltrexone—alcohol dependence	0.00114	0.00191	CcSEcCtD
Fosaprepitant—Angioedema—Citalopram—alcohol dependence	0.00113	0.00188	CcSEcCtD
Fosaprepitant—Pruritus—Naltrexone—alcohol dependence	0.00112	0.00188	CcSEcCtD
Fosaprepitant—Malaise—Citalopram—alcohol dependence	0.00111	0.00186	CcSEcCtD
Fosaprepitant—Dizziness—Acamprosate—alcohol dependence	0.00111	0.00186	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR1B—alcohol dependence	0.00111	0.00447	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CRH—alcohol dependence	0.00111	0.00447	CbGpPWpGaD
Fosaprepitant—Syncope—Citalopram—alcohol dependence	0.0011	0.00185	CcSEcCtD
Fosaprepitant—Palpitations—Citalopram—alcohol dependence	0.00109	0.00182	CcSEcCtD
Fosaprepitant—Diarrhoea—Naltrexone—alcohol dependence	0.00109	0.00182	CcSEcCtD
Fosaprepitant—Loss of consciousness—Citalopram—alcohol dependence	0.00108	0.00181	CcSEcCtD
Fosaprepitant—Cough—Citalopram—alcohol dependence	0.00108	0.0018	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—DRD4—alcohol dependence	0.00107	0.0043	CbGpPWpGaD
Fosaprepitant—Vomiting—Acamprosate—alcohol dependence	0.00107	0.00179	CcSEcCtD
Fosaprepitant—Hypertension—Citalopram—alcohol dependence	0.00106	0.00178	CcSEcCtD
Fosaprepitant—Rash—Acamprosate—alcohol dependence	0.00106	0.00177	CcSEcCtD
Fosaprepitant—Dermatitis—Acamprosate—alcohol dependence	0.00106	0.00177	CcSEcCtD
Fosaprepitant—Headache—Acamprosate—alcohol dependence	0.00105	0.00176	CcSEcCtD
Fosaprepitant—Dizziness—Naltrexone—alcohol dependence	0.00105	0.00176	CcSEcCtD
Fosaprepitant—Chest pain—Citalopram—alcohol dependence	0.00105	0.00176	CcSEcCtD
Fosaprepitant—Anxiety—Citalopram—alcohol dependence	0.00105	0.00175	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00104	0.00174	CcSEcCtD
Fosaprepitant—Discomfort—Citalopram—alcohol dependence	0.00104	0.00173	CcSEcCtD
Fosaprepitant—Dry mouth—Citalopram—alcohol dependence	0.00103	0.00172	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CNR1—alcohol dependence	0.00102	0.0041	CbGpPWpGaD
Fosaprepitant—Vomiting—Naltrexone—alcohol dependence	0.00101	0.00169	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Citalopram—alcohol dependence	0.00101	0.00168	CcSEcCtD
Fosaprepitant—Oedema—Citalopram—alcohol dependence	0.00101	0.00168	CcSEcCtD
Fosaprepitant—Rash—Naltrexone—alcohol dependence	0.001	0.00167	CcSEcCtD
Fosaprepitant—Dermatitis—Naltrexone—alcohol dependence	0.001	0.00167	CcSEcCtD
Fosaprepitant—Infection—Citalopram—alcohol dependence	0.000999	0.00167	CcSEcCtD
Fosaprepitant—Nausea—Acamprosate—alcohol dependence	0.000996	0.00167	CcSEcCtD
Fosaprepitant—Headache—Naltrexone—alcohol dependence	0.000994	0.00166	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—DRD2—alcohol dependence	0.000994	0.004	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR7—alcohol dependence	0.000994	0.004	CbGpPWpGaD
Fosaprepitant—Shock—Citalopram—alcohol dependence	0.000989	0.00166	CcSEcCtD
Fosaprepitant—Nervous system disorder—Citalopram—alcohol dependence	0.000986	0.00165	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—alcohol dependence	0.000984	0.00396	CbGpPWpGaD
Fosaprepitant—Skin disorder—Citalopram—alcohol dependence	0.000977	0.00163	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Citalopram—alcohol dependence	0.000972	0.00163	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—DRD4—alcohol dependence	0.000969	0.0039	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—OPRD1—alcohol dependence	0.000958	0.00386	CbGpPWpGaD
Fosaprepitant—Nausea—Naltrexone—alcohol dependence	0.000943	0.00158	CcSEcCtD
Fosaprepitant—Hypotension—Citalopram—alcohol dependence	0.00094	0.00157	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CNR1—alcohol dependence	0.000925	0.00373	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDYN—alcohol dependence	0.000919	0.0037	CbGpPWpGaD
Fosaprepitant—Insomnia—Citalopram—alcohol dependence	0.000909	0.00152	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—DRD2—alcohol dependence	0.000902	0.00364	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR7—alcohol dependence	0.000902	0.00364	CbGpPWpGaD
Fosaprepitant—Dyspnoea—Citalopram—alcohol dependence	0.000896	0.0015	CcSEcCtD
Fosaprepitant—Somnolence—Citalopram—alcohol dependence	0.000894	0.0015	CcSEcCtD
Fosaprepitant—Dyspepsia—Citalopram—alcohol dependence	0.000885	0.00148	CcSEcCtD
Fosaprepitant—Decreased appetite—Citalopram—alcohol dependence	0.000874	0.00146	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000868	0.00145	CcSEcCtD
Fosaprepitant—Fatigue—Citalopram—alcohol dependence	0.000867	0.00145	CcSEcCtD
Fosaprepitant—Pain—Citalopram—alcohol dependence	0.00086	0.00144	CcSEcCtD
Fosaprepitant—Constipation—Citalopram—alcohol dependence	0.00086	0.00144	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CRHR1—alcohol dependence	0.000854	0.00344	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—WASF2—alcohol dependence	0.000854	0.00344	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AVP—alcohol dependence	0.000836	0.00337	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Citalopram—alcohol dependence	0.000829	0.00139	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Citalopram—alcohol dependence	0.000822	0.00138	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—WASF1—alcohol dependence	0.000819	0.0033	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CHRM2—alcohol dependence	0.000803	0.00324	CbGpPWpGaD
Fosaprepitant—Urticaria—Citalopram—alcohol dependence	0.000799	0.00134	CcSEcCtD
Fosaprepitant—Body temperature increased—Citalopram—alcohol dependence	0.000795	0.00133	CcSEcCtD
Fosaprepitant—Abdominal pain—Citalopram—alcohol dependence	0.000795	0.00133	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AVP—alcohol dependence	0.00076	0.00306	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Citalopram—alcohol dependence	0.000741	0.00124	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—OPRM1—alcohol dependence	0.000737	0.00297	CbGpPWpGaD
Fosaprepitant—Asthenia—Citalopram—alcohol dependence	0.000721	0.00121	CcSEcCtD
Fosaprepitant—Pruritus—Citalopram—alcohol dependence	0.000711	0.00119	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000696	0.0028	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Citalopram—alcohol dependence	0.000688	0.00115	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NPY—alcohol dependence	0.000679	0.00273	CbGpPWpGaD
Fosaprepitant—Dizziness—Citalopram—alcohol dependence	0.000665	0.00111	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CRH—alcohol dependence	0.000655	0.00264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR1B—alcohol dependence	0.000655	0.00264	CbGpPWpGaD
Fosaprepitant—Vomiting—Citalopram—alcohol dependence	0.000639	0.00107	CcSEcCtD
Fosaprepitant—Rash—Citalopram—alcohol dependence	0.000634	0.00106	CcSEcCtD
Fosaprepitant—Dermatitis—Citalopram—alcohol dependence	0.000633	0.00106	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—alcohol dependence	0.000632	0.00255	CbGpPWpGaD
Fosaprepitant—Headache—Citalopram—alcohol dependence	0.00063	0.00105	CcSEcCtD
Fosaprepitant—Nausea—Citalopram—alcohol dependence	0.000597	0.001	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—DRD4—alcohol dependence	0.000572	0.00231	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—alcohol dependence	0.000556	0.00224	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CNR1—alcohol dependence	0.000546	0.0022	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DRD2—alcohol dependence	0.000533	0.00215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR7—alcohol dependence	0.000533	0.00215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—alcohol dependence	0.000505	0.00203	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AVP—alcohol dependence	0.000449	0.00181	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—alcohol dependence	0.000373	0.0015	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—alcohol dependence	0.000298	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EP300—alcohol dependence	0.000198	0.000797	CbGpPWpGaD
